The National Institutes of Health has begun two late stage studies of blood thinners to treat COVID-19. The studies will test whether the blood thinners can help severely ill COVID-19 patients as well as those with more mild illness. Bristol Myers Squibb and Pfizer will donate Eliquis and aspirin to the effort. (BioPharma Dive)

Global confidence in vaccines may pose a challenge for the COVID-19 vaccine. In countries like South Korea, Indonesia, Pakistan and Poland, confidence in vaccines has declined in recent years, according to a study. But there are also signs of trust rising in countries like Finland, France, Italy, Ireland and the U.K. (Bloomberg)

The pandemic took a greater toll on the mental health of younger adults, according to a poll. More than half of adults between 18 and 34 reported feeling isolated and about a quarter rated their mental health as fair or poor, compared with 13% of older adults. (Associated Press)

Dining out has a higher risk of catching COVID-19 than other activities, according to a report from the Centers for Disease Control and Prevention. The report surveyed 314 people and found those with COVID-19 symptoms and found were approximately twice as likely to have reported dining at a restaurant. (CNBC)

Register to attend MM+M’s upcoming webcast “Maximize Your Marketing Efforts with Partner Alignment.” Speakers will include leaders from Veeva, AbbVie and Crossix discussing how to maximize the impact of your marketing investments. The webcast is on September 24. (MM+M)